Paris
France
43
2024-02-22
29
2026-06-09
These are the the leading inventors for applications assigned to AB SCIENCE:
AB SCIENCE based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MASITINIB FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#2 | 2023-10-12 ✅ Patent 12,648,944 granted on 2026-06-09MASITINIB FOR THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER
#3 | 2023-07-20USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)
#4 | 2023-03-23MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT SUBPOPULATION
#5 | 2023-01-26USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMA
#6 | 2023-01-05 ✅ Patent 12,472,164 granted on 2025-11-18MASITINIB FOR THE TREATMENT OF SICKLE CELL DISEASE
#7 | 2019-02-21 ✅ Patent 10,392,373 granted on 2019-08-27Oxazole derivatives that inhibit Syk
#8 | 2018-06-28 ✅ Patent 10,053,455 granted on 2018-08-21Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
#9 | 2018-05-03 ✅ Patent 10,092,564 granted on 2018-10-09Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
#10 | 2018-03-22 ✅ Patent 10,570,122 granted on 2020-02-25Compounds with anti-tumoral activity
#11 | 2017-11-30MASITINIB COMBINATION FOR USE IN TREATING BREAST CANCER
#12 | 2016-08-25METHOD FOR DETERMINING THE PROGNOSIS OF PANCREATIC CANCER
#13 | 2016-06-02 ✅ Patent 10,202,370 granted on 2019-02-12Benzimidazole derivatives as selective proteine kinase inhibitors
#14 | 2016-03-31 ✅ Patent 10,045,978 granted on 2018-08-14Treatment of mastocytosis with masitinib
#15 | 2015-10-01 ✅ Patent 10,238,649 granted on 2019-03-26Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors
#16 | 2014-06-26 ✅ Patent 9,168,245 granted on 2015-10-27Selective protein kinase inhibitors
#17 | 2014-05-29TREATMENT OF MASTOCYTOSIS WITH MASITINIB
#18 | 2014-03-27 ✅ Patent 8,993,573 granted on 2015-03-312-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
#19 | 2014-02-20TREATMENT OF MULTIPLE MYELOMA WITH MASITINIB
#20 | 2014-02-13 ✅ Patent 9,078,894 granted on 2015-07-14Treatment of severe persistant asthma with masitinib
#21 | 2013-10-31 ✅ Patent 8,940,894 granted on 2015-01-27Aminothiazole compounds as kinase inhibitors and methods of using the same
#22 | 2013-10-10TREATMENT OF RHEUMATOID ARTHRITIS WITH MASITINIB
#23 | 2013-08-08 ✅ Patent 8,906,357 granted on 2014-12-09Treatment of multiple sclerosis with masitinib
#24 | 2013-03-21TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE WITH MASITINIB
#25 | 2013-02-07 ✅ Patent 8,962,665 granted on 2015-02-24Thiazole and oxazole kinase inhibitors
#26 | 2012-12-06COMBINED TREATMENT OF PANCREATIC CANCER WITH GEMCITABINE AND MASITINIB
#27 | 2012-11-29TREATMENT OF GIST WITH MASITINIB
#28 | 2012-08-02 ✅ Patent 8,492,545 granted on 2013-07-23Aminothiazole compounds as kinase inhibitors and methods of using the same
#29 | 2012-05-03 ✅ Patent 8,658,659 granted on 2014-02-25Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
#30 | 2012-03-01 ✅ Patent 8,835,435 granted on 2014-09-162-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
#31 | 2011-08-18 ✅ Patent 8,450,302 granted on 2013-05-282-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
#32 | 2010-05-13 ✅ Patent 8,153,792 granted on 2012-04-10Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
#33 | 2010-05-06 ✅ Patent 8,110,591 granted on 2012-02-072-aminoaryloxazole compounds as tyrosine kinase inhibitors
#34 | 2010-04-20 ✅ Patent 7,700,610 granted on 2010-04-20Use of tyrosine kinase inhibitors for treating allergic diseases
#35 | 2010-04-15 ✅ Patent 8,227,470 granted on 2012-07-24Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
#36 | 2010-03-16 ✅ Patent 7,678,805 granted on 2010-03-16Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
#37 | 2009-07-30 ✅ Patent 8,080,669 granted on 2011-12-20Process for the synthesis of 2-aminoxazole compounds
#38 | 2009-03-26Use of tyrosine kinase inhibitors for treating CNS disorders
#39 | 2008-09-09 ✅ Patent 7,423,055 granted on 2008-09-092-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases
#40 | 2007-06-21 ✅ Patent 7,718,676 granted on 2010-05-182-aminoaryloxazole compounds as tyrosine kinase inhibitors
#41 | 2006-07-27 ✅ Patent 7,727,731 granted on 2010-06-01Potent, selective and non toxic c-kit inhibitors
#42 | 2005-10-272-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
#43 | 2005-03-17 ✅ Patent 7,741,335 granted on 2010-06-22Use of tyrosine kinase inhibitors for treating inflammatory diseases
Also check out AB Science's (Paris, France) applicant profile with 11 patent applications submitted.
8390 ⎘